Results per Page:
New assay better predicts treatment for two cancers
Fred Hutch researchers develop HRDefine, new clinical test to better serve patients with tubo-ovarian and triple-negative breast cancer
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
September 09, 2026
Dr. Lynn Symonds receives ASCO Career Development Award
‘Homegrown’ Fred Hutch clinician-scholar honored for research on triple-negative breast cancer